Context-dependent role of ATG4B as target for autophagy inhibition in prostate cancer therapy
Authors:
- Annabelle ChowACAnnabelle Chow
- Takeshi GodaTGTakeshi Goda
- Amy WongAWAmy Wong
- Kim BlakelyKBKim Blakely
- Michelle RochaMRMichelle Rocha
- Samira TaebSTSamira Taeb
- Van C. HoangVHVan C. Hoang
- Stanley K. LiuSLStanley K. Liu
- Urban EmmeneggerUEUrban Emmenegger
- 1 November 2013
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 441 (4) , 726-731
Abstract
No abstract availableKeywords
Funding Information
- Prostate Cancer Canada
This publication has 33 references indexed in Scilit:
- Autophagy in Human Health and DiseaseNew England Journal of Medicine, 2013
- Chloroquine in Cancer Therapy: A Double-Edged Sword of AutophagyCancer Research, 2013
- Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiencyProceedings of the National Academy of Sciences, 2012
- Deconvoluting the context-dependent role for autophagy in cancerNature Reviews Cancer, 2012
- The end of autophagic cell death?Autophagy, 2012
- The Role of Autophagy in Cancer: Therapeutic ImplicationsMolecular Cancer Therapeutics, 2011
- High-Throughput Fluorescence Assay for Small-Molecule Inhibitors of Autophagins/Atg4SLAS Discovery, 2011
- Autophagy and the Integrated Stress ResponseMolecular Cell, 2010
- Chloroquine and its analogs: A new promise of an old drug for effective and safe cancer therapiesEuropean Journal of Pharmacology, 2009
- Clinical Pharmacokinetics and Metabolism of ChloroquineClinical Pharmacokinetics, 1996